COF
GILD icon

Capital One Financial’s Gilead Sciences GILD Stock Holding History

Capital One Financial’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-4,487
Closed -$284K – 216
2020
Q3 		$284K Sell
4,487
-608
-12% -$42.2K 0.04% 215
2020
Q2 		$392K Sell
5,095
-1,962
-28% -$150K 0.05% 208
2020
Q1 		$528K Buy
+7,057
New +$488K 0.09% 181

Other funds holding GILD

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Capital One Financial's GILD Position: Q4 2020 in Review

Capital One Financial sold out of Gilead Sciences (GILD) in Q4 2020, closing a stake of 4,487 shares — an estimated $284K sold.

Capital One Financial first reported a position in GILD in Q1 2020 and held it in 3 quarters. The position peaked at $528K in Q1 2020. 1,564 funds tracked by Wall St. Rank hold GILD as of Q4 2020.

  • Capital One Financial reported no remaining Gilead Sciences position as of Q4 2020 after selling out during the quarter.
  • Capital One Financial sold 4,487 Gilead Sciences shares in Q4 2020, an estimated $284K.
  • Capital One Financial first reported a position in Gilead Sciences in Q1 2020 and held it in 3 quarters.
  • Capital One Financial's Gilead Sciences position peaked at $528K in Q1 2020.
  • 1,564 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2020.

Based on Capital One Financial's 13F filing for Q4 2020, filed 11 Feb 2021.